America's Drug Supply Chain

The U.S. faces critical vulnerabilities in its pharmaceutical supply chain due to heavy reliance on China for key drug ingredients and manufacturing, jeopardizing domestic biotech innovation and production capacity. Congressional recommendations focus on securing supply chains, reshoring biotech manufacture, and tightening regulatory oversight on foreign biotech investments.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.